Syndax Pharmaceuticals, Inc. (SNDX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -50.34M | -69.49M | -70.53M | -87.8M | -95.16M | -57.39M | -62.32M | -71.64M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.71M | -24.94M | -24.05M |
| Operating CF Margin % | -77.62% | -101.47% | -153.77% | -231.3% | -474.81% | -747.24% | -498.58% | -2047% | - | - | - | - | - | - | - | - | - | 79.56% | -201.57% | -6344.33% |
| Operating CF Growth % | 47.1% | -21.08% | -13.18% | -22.54% | -13.9% | -38.79% | -39.57% | -102.55% | -112.98% | -80.61% | -56.44% | 12.24% | 6.45% | -122.73% | -14.43% | -67.63% | -85.63% | 744.29% | -36.33% | -12.32% |
| Net Income | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M |
| Depreciation & Amortization | 4K | 3K | -164K | 55K | 0 | 0 | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 8K | 11K | 11K | 10K | 8K | 9K |
| Stock-Based Compensation | 12.05M | 11.25M | 12.08M | 13.79M | 10.38M | 12.3M | 11.93M | 9.9M | 8.9M | 8.33M | 8.32M | 8.06M | 6.24M | 4.24M | 4.36M | 3.94M | 3.48M | 3.93M | 3.38M | 3.24M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -19.73M | -973K | 1.64M | -3.04M | -3.27M | -2.7M | -2.76M | -3.41M | -3.58M | -3.22M | -3.42M | -3.57M | -3.86M | -1.91M | -145K | -9K | 22K | -690K | 401K | 403K |
| Working Capital Changes | 0 | -11.76M | -23.38M | -26.75M | -17.43M | 27.19M | 12.63M | -10.07M | -16.47M | 26.01M | 1.59M | 4.75M | -486K | 13.97M | 2.63M | -6.67M | -8.27M | 1.26M | -8.1M | -4.79M |
| Change in Receivables | -120K | -19M | -5.99M | -3.77M | -8.07M | -6M | 4.35M | -3.51M | -6.07M | 0 | -3.9M | 3.97M | 0 | 1.06M | 8.56M | -6.84M | -6.26M | 0 | 0 | 0 |
| Change in Inventory | -2.06M | -7.8M | -7.18M | -12.92M | -4.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.74M | 2.75M | -3.53M | 7.31M | -1.58M | 6.73M | -6.67M | 2.76M | -1.15M | 3.91M | -4.93M | 2.92M | 3.71M | -2.76M | 676K | -1.79M | 2.56M | 547K | 1.5M | -2.9M |
| Cash from Investing | 38.39M | 81.58M | 72.43M | 41.89M | 94.14M | -268.97M | 86.85M | 61.75M | -99.4M | -16.29M | 40.08M | 73.91M | 19.91M | -137.63M | -6.79M | -49.95M | 8.18M | -59.96M | 26.63M | 21.68M |
| Capital Expenditures | 0 | -56K | -131K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | 0.08% | 0.29% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 225K | 0 | 0 | -129K | 0 | 0 |
| Cash from Financing | 7.92M | 5.92M | 6.28M | 551K | 930K | 347.43M | 3.1M | 676K | 2.17M | 258.48M | 1.85M | 1.32M | 2.47M | 163.5M | -13.53M | 21.72M | 557K | 109.78M | 1.71M | 6.02M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 5.92M | 6.28M | 551K | 0 | 0 | 0 | 0 | 0 | 258.09M | 0 | 0 | 0 | 162.36M | 0 | 0 | 0 | 81.21M | 0 | 5.13M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 7.92M | 0 | 0 | 0 | 930K | 347.43M | 3.1M | 676K | 2.17M | 389K | 1.85M | 1.32M | 2.47M | 1.14M | -13.53M | 21.72M | 557K | 28.57M | 1.71M | 889K |
| Net Change in Cash | -4.04M | 18.01M | 8.17M | -45.36M | -90K | 21.06M | 27.62M | -9.22M | -180.78M | 200.84M | -2.73M | 39.86M | -16.84M | 2.98M | -48.86M | -68.53M | -33.19M | 150.53M | 3.39M | 3.65M |
| Free Cash Flow | -50.34M | -69.54M | -70.67M | -87.8M | -95.16M | -57.39M | -62.32M | -71.64M | -83.55M | -41.35M | -44.65M | -35.37M | -39.23M | -22.89M | -28.54M | -40.31M | -41.93M | 100.58M | -24.94M | -24.05M |
| FCF Margin % | -77.62% | -101.55% | -154.05% | -231.3% | -474.81% | -747.24% | -498.58% | -2047% | - | - | - | - | - | - | - | - | - | 79.46% | -201.57% | -6344.33% |
| FCF Growth % | 47.1% | -21.18% | -13.39% | -22.54% | -13.9% | -38.79% | -39.57% | -102.55% | -112.98% | -80.61% | -56.44% | 12.24% | 6.45% | -122.76% | -14.43% | -67.63% | -85.63% | 743.46% | -36.33% | -12.32% |
| FCF per Share | -0.57 | -0.80 | -0.82 | -1.02 | -1.11 | -0.67 | -0.73 | -0.84 | -0.98 | -0.57 | -0.64 | -0.51 | -0.56 | -0.36 | -0.47 | -0.67 | -0.71 | 1.89 | -0.48 | -0.47 |
| FCF Conversion (FCF/Net Income) | 1.18x | 1.02x | 1.16x | 1.22x | 1.12x | 0.61x | 0.74x | 1.05x | 1.15x | 0.57x | 0.87x | 0.79x | 0.95x | 0.58x | 0.81x | 1.07x | 1.13x | 1.05x | 1.21x | 1.05x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1M | 490K | 470K | 0 | 503K | 503K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |